Demographic and Clinical Characteristics of Regular GHB-Users with and without GHB-Induced Comas

References

• Abanades, S., Farré, M., Segura, M., Pichini, S., Barral, D., Pacifici, R., Pellegrini, M., Fonseca, F., Langohr, K., & De La Torre, R. (2006). Gamma-hydroxybutyrate (GHB) in humans: Pharmacodynamics and pharmacokinetics. Annals of the New York Academy of Sciences, 1074, 559–576. https://doi.org/10.1196/annals.1369.065
   PubMed Web of Science ®Google Scholar
• Barker, J. C., Harris, S. L., & Dyer, J. E. (2007). Experiences of gamma hydroxybutyrate (GHB) ingestion: A focus group study. Journal of Psychoactive Drugs, 39(2), 115–129. https://doi.org/10.1080/02791072.2007.10399870
   PubMed Web of Science ®Google Scholar
• Beurmanjer, H., Verbrugge, C., & de Jong, C. A. (2016). GHB monitor 2.0. NISPA.
   Google Scholar
• Bosch, O. G., Havranek, M. M., Baumberger, A., Preller, K. H., von Rotz, R., Herdener, M., Kraehenmann, R., Staempfli, P., Scheidegger, M., Klucken, T., Seifritz, E., & Quednow, B. B. (2017). Neural underpinnings of prosexual effects induced by gamma-hydroxybutyrate in healthy male humans. European Neuropsychopharmacology, 27(4), 372–382. https://doi.org/10.1016/j.euroneuro.2017.02.006
   PubMed Web of Science ®Google Scholar
• Bosch, O. G., Quednow, B. B., Seifritz, E., & Wetter, T. C. (2012). Reconsidering GHB: Orphan drug or new model antidepressant? Journal of Psychopharmacology (Oxford, England), 26(5), 618–628. https://doi.org/10.1177/0269881111421975
   PubMed Web of Science ®Google Scholar
• Brady, K. T., & Sinha, R. (2005). Co-occurring mental and substance use disorders: The neurobiological effects of chronic stress. The American Journal of Psychiatry, 162(8), 1483–1493. https://doi.org/10.1176/appi.ajp.162.8.1483
   PubMed Web of Science ®Google Scholar
• Brenneisen, R., Elsohly, M. A., Murphy, T. P., Passarelli, J., Russmann, S., Salamone, S. J., & Watson, D. E. (2004). Pharmacokinetics and excretion of gamma-hydroxybutyrate (GHB) in healthy subjects. Journal of Analytical Toxicology, 28(8), 625–630. https://doi.org/10.1093/jat/28.8.625
   PubMed Web of Science ®Google Scholar
• Brunt TM, Koeter MW, Hertoghs N, van Noorden MS, van den Brink W. (2013). Sociodemographic and substance use characteristics of gamma hydroxybutyrate (GHB) dependent inpatients and associations with dependence severity. Drug Alcohol Depend, 131, 316–319.
   Google Scholar
• Büller, H. R., Fliers, E., De Haes, J. C. J. M., Medema, J. P., & Oude Elferink, R. P. J. (2010). Research code AMC independence in scientific research.
   Google Scholar
• Carter, L. P., Pardi, D., Gorsline, J., & Griffiths, R. R. (2009). Illicit gamma-hydroxybutyrate (GHB) and pharmaceutical sodium oxybate (Xyrem): Differences in characteristics and misuse. Drug and Alcohol Dependence, 104(1–2), 1–10. https://doi.org/10.1016/j.drugalcdep.2009.04.012
   PubMed Web of Science ®Google Scholar
• Carter, L. P., Richards, B. D., Mintzer, M. Z., & Griffiths, R. R. (2006). Relative abuse liability of GHB in humans: A comparison of psychomotor, subjective, and cognitive effects of supratherapeutic doses of triazolam, pentobarbital, and GHB. Neuropsychopharmacology, 31(11), 2537–2551. https://doi.org/10.1038/sj.npp.1301146
   PubMed Web of Science ®Google Scholar
• Caselli, G., & Spada, M. M. (2011). The desire thinking questionnaire: Development and psychometric properties. Addictive Behaviors, 36(11), 1061–1067. https://doi.org/10.1016/j.addbeh.2011.06.013
   PubMed Web of Science ®Google Scholar
• Choudhuri, D., Cross, S., Dargan, P. I., Wood, D. M., & Ranjith, G. (2013). Psychiatric aspects of acute withdrawal from gamma-hydroxybutyrate (GHB) and its analogue gamma-butyrolactone (GBL): Implications for psychiatry services in the general hospital. International Journal of Psychiatry in Clinical Practice, 17(2), 154–156. https://doi.org/10.3109/13651501.2013.784790
   PubMed Web of Science ®Google Scholar
• De Jong, C., & Dijkstra, B. (2013). GHB monitor – GHB detoxificatie met farmaceutische GHB. Nijmegen Institute for Scientist Practitioners in Addiction (NISPA).
   Google Scholar
• Dijkstra, B. A. G., Kamal, R., van Noorden, M. S., de Haan, H., Loonen, A. J. M., & De Jong, C. A. J. (2017). Detoxification with titration and tapering in gamma-hydroxybutyrate (GHB) dependent patients: The Dutch GHB monitor project. Drug and Alcohol Dependence, 170, 164–173. https://doi.org/10.1016/j.drugalcdep.2016.11.014
   PubMed Web of Science ®Google Scholar
• European Monitoring Centre for Drugs and Drug Addiction. (2018). European drug report trends and developments. Publications Office of the European Union.
   Google Scholar
• Gonzalez, A., & Nutt, D. J. (2005). Gamma hydroxy butyrate abuse and dependency. Journal of Psychopharmacology, 19(2), 195–204. https://doi.org/10.1177/0269881105049041
   PubMed Web of Science ®Google Scholar
• Hyman, S. E., Malenka, R. C., & Nestler, E. J. (2006). Neural mechanisms of addiction: The role of reward-related learning and memory. Annual Review of Neuroscience, 29(1), 565–598. https://doi.org/10.1146/annurev.neuro.29.051605.113009
   PubMed Web of Science ®Google Scholar
• Kamal, R. M., Dijkstra, B. A. G., de Weert-van Oene, G. H., van Duren, J. A. M., & de Jong, C. A. J. (2017). Psychiatric comorbidity, psychological distress, and quality of life in gamma-hydroxybutyrate-dependent patients. Journal of Addictive Diseases, 36(1), 72–79. https://doi.org/10.1080/10550887.2016.1214000
   PubMed Web of Science ®Google Scholar
• Kamal, R. M., Dijkstra, B. A. G., Loonen, A. J., & De Jong, C. A. J. (2016). The effect of co-occurring substance use on gamma-hydroxybutyric acid withdrawal syndrome. Journal of Addiction Medicine, 10(4), 229–235. https://doi.org/10.1097/ADM.0000000000000214
   PubMed Web of Science ®Google Scholar
• Kamal, R. M., Schellekens, A., De Jong, C. A. J., & Dijkstra, B. A. G. (2015). Baclofen as relapse prevention in the treatment of gamma-hydroxybutyrate (GHB) dependence: An open label study. BMC Psychiatry, 15, 91. https://doi.org/10.1186/s12888-015-0471-4
   PubMed Web of Science ®Google Scholar
• Kamal, R. M., Van Noorden, M. S., Franzek, E., Dijkstra, B. A. G., Loonen, A. J. M., & De Jong, C. A. J. (2016). The neurobiological mechanisms of gamma-hydroxybutyrate dependence and withdrawal and their clinical relevance: A review. Neuropsychobiology, 73(2), 65–80. https://doi.org/10.1159/000443173
   PubMed Web of Science ®Google Scholar
• Kapitány-Fövény, M., Mervó, B., Corazza, O., Kökönyei, G., Farkas, J., Urbán, R., Zacher, G., & Demetrovics, Z. (2015). Enhancing sexual desire and experience: An investigation of the sexual correlates of gamma-hydroxybutyrate (GHB) use. Human Psychopharmacology, 30(4), 276–284. https://doi.org/10.1002/hup.2491
   PubMed Web of Science ®Google Scholar
• Kapoor P, Kukreja I, Deshmukh R. (2013). GHB acid: A rage or reprive. J Adv Pharm Technol Res, 4, 173–178.
   Google Scholar
• Koob, G. F., & Volkow, N. D. (2010). Neurocircuitry of addiction. Neuropsychopharmacology, 35(1), 217–238. https://doi.org/10.1038/npp.2009.110
   PubMed Web of Science ®Google Scholar
• Korf, D. J., Nabben, T., Benschop, A., Ribbink, K., & Van Amsterdam, J. G. C. (2014). Risk factors of γ-hydroxybutyrate overdosing. European Addiction Research, 20(2), 66–74. https://doi.org/10.1159/000353237
   PubMed Web of Science ®Google Scholar
• Liakoni, E., Walther, F., Nickel, C. H., & Liechti, M. E. (2016). Presentations to an urban emergency department in Switzerland due to acute γ-hydroxybutyrate toxicity. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine, 24(1), 107. https://doi.org/10.1186/s13049-016-0299-z
   PubMedGoogle Scholar
• Liechti, M. E., Quednow, B. B., Liakoni, E., Dornbierer, D., von Rotz, R., Gachet, M. S., Gertsch, J., Seifritz, E., & Bosch, O. G. (2016). Pharmacokinetics and pharmacodynamics of γ-hydroxybutyrate in healthy subjects. British Journal of Clinical Pharmacology, 81(5), 980–988. https://doi.org/10.1111/bcp.12863
   PubMed Web of Science ®Google Scholar
• Lovibond, S. H., & Lovibond, P. F. (1995). Manual for the depression anxiety stress scales (2nd. ed.). Psychology Foundation.
   Google Scholar
• Madah-Amiri, D., Myrmel, L., & Brattebø, G. (2017). Intoxication with GHB/GBL: Characteristics and trends from ambulance-attended overdoses. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine, 25(1), 98. https://doi.org/10.1186/s13049-017-0441-6
   Google Scholar
• Metcalf, D. R., Emde, R. N., & Stripe, J. T. (1966). An EEG-behavioral study of sodium hydroxybutyrate in humans. Electroencephalography and Clinical Neurophysiology, 20(5), 506–512. https://doi.org/10.1016/0013-4694(66)90107-6
   PubMedGoogle Scholar
• Miotto, K., Darakjian, J., Basch, J., Murray, S., Zogg, J., & Rawson, R. (2001). Gamma-hydroxybutyric acid: Patterns of use, effects and withdrawal. The American Journal on Addictions, 10(3), 232–241. https://doi.org/10.1080/105504901750532111
   PubMed Web of Science ®Google Scholar
• Miró, Ò., Galicia, M., Dargan, P., Dines, A. M., Giraudon, I., Heyerdahl, F., Hovda, K. E., Yates, C., Wood, D. M., Liakoni, E., Liechti, M., Jürgens, G., Pedersen, C. B., O’Connor, N., Markey, G., Moughty, A., Lee, C., O’Donohoe, P., Sein Anand, J., … Kabata, P. M. (2017). Intoxication by gamma hydroxybutyrate and related analogues: Clinical characteristics and comparison between pure intoxication and that combined with other substances of abuse. Toxicology Letters, 277, 84–91. https://doi.org/10.1016/j.toxlet.2017.05.030
   PubMed Web of Science ®Google Scholar
• Nayak, C., Nayak, D., Raja, A., & Rao, A. (2006). Time-level relationship between indicators of oxidative stress and Glasgow Coma Scale scores of severe head injury patients. Clinical Chemistry and Laboratory Medicine, 44(4), 460–463.
   PubMed Web of Science ®Google Scholar
• Palamar, J. J., & Halkitis, P. N. (2006). A qualitative analysis of GHB use among gay men: Reasons for use despite potential adverse outcomes. The International Journal on Drug Policy, 17(1), 23–28. https://doi.org/10.1016/j.drugpo.2005.11.002
   PubMed Web of Science ®Google Scholar
• Patton, J., Stanford, M., & Barrat, E. (1995). Factors structure of the barrat impulsivity scale. Journal of Clinical Psychology, 51(6), 768–774. https://doi.org/10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1
   PubMed Web of Science ®Google Scholar
• Perouansky, M., & Hemmings, H. C. (2009). Neurotoxicity of general anesthetics: Cause for concern? Why suspect long-term neurological effects of anesthetics? Anesthesiology, 111(6), 1365–1371. https://doi.org/10.1097/ALN.0b013e3181bf1d61
   PubMed Web of Science ®Google Scholar
• Public Health England. (2016). Adult substance misuse statistics from the National Drug Treatment Monitoring System (NDTMS). https://www.gov.uk/phe
   Google Scholar
• Raposo Pereira, F., McMaster, M. T. B., De Vries, Y. D. A. T., Polderman, N., Van Den Brink, W., & Van Wingen, G. A. (2019). Influence of gamma-hydroxybutyric acid-use and gamma-hydroxybutyric acid-induced coma on affect and the affective network. European Addiction Research, 25(4), 173–181. https://doi.org/10.1159/000497381
   PubMed Web of Science ®Google Scholar
• Raposo Pereira, F., McMaster, M. T. B., Polderman, N., de Vries, Y. D. A. T., van den Brink, W., & van Wingen, G. A. (2018a). Adverse effects of GHB-induced coma on long-term memory and related brain function. Drug and Alcohol Dependence, 190, 29–36. https://doi.org/10.1016/j.drugalcdep.2018.05.019
   PubMed Web of Science ®Google Scholar
• Raposo Pereira, F., McMaster, M. T., Polderman, N., de Vries, Y. D., van den Brink, W., & van Wingen, G. A. (2018b). Effect of GHB-use and GHB-induced comas on dorsolateral prefrontal cortex functioning in humans. NeuroImage: Clinical, 20, 923–930. https://doi.org/10.1016/j.nicl.2018.09.022
   PubMed Web of Science ®Google Scholar
• Raposo Pereira, F., Zhutovsky, P., Mcmaster, M. T. B., Polderman, N., de Vries, Y. D. A. T., van den Brink, W., & van Wingen, G. A. (2019). Recreational use of GHB is associated with alterations of resting state functional connectivity of the central executive and default mode networks. Human Brain Mapping, 40(8), 2413–2421. https://doi.org/10.1002/hbm.24532
   PubMed Web of Science ®Google Scholar
• Schippers, G. M., Broekman, T. G., & Buchholz, A. (2011). In W. M. Cox (Ed.) MATE-en 2.1 Manual and protocol-D (English edition). Bureau Bêta.
   Google Scholar
• Schmand, B., Bakker, D., Saan, R., & Louman, J. (1991). The Dutch reading test for adults: A measure of premorbid intelligence level. Tijdschrift Voor Gerontologie en Geriatrie, 22(1), 15–19.
   PubMedGoogle Scholar
• Sesack, S. R., & Grace, A. A. (2010). Cortico-basal ganglia reward network: Microcircuitry. Neuropsychopharmacology, 35(1), 27–47. https://doi.org/10.1038/npp.2009.93
   PubMed Web of Science ®Google Scholar
• Snyder, B., Shell, B., Cunningham, J. T., & Cunningham, R. L. (2017). Chronic intermittent hypoxia induces oxidative stress and inflammation in brain regions associated with early-stage neurodegeneration. Physiological Reports, 5(9), e13258. https://doi.org/10.14814/phy2.13258
   PubMed Web of Science ®Google Scholar
• United Nations Office on Drugs and Crime. (2017). World drug report – Market analysis of synthetic drugs. United Nations publication.
   Google Scholar
• Uporova, J., Karlsson, A., Sutherland, R., & Burns, L. (2018). Australian Trends in Ecstasy and related Drug Markets 2017. Findings from the Ecstasy and Related Drugs Reporting System (EDRS). Australian Drug Trends Series No. 190. Sydney.
   Google Scholar
• Van Amsterdam, J. G. C., Brunt, T. M., McMaster, M. T. B., & Van den Brink, W. (2016). Neurotoxicity due to repeated comas following excessive use of gamma-hydroxybutyric acid. Neuropathology of Drug Addictions and Substance Misuse, 2, 453–459.
   Google Scholar
• van Noorden, M. S., Mol, T., Wisselink, J., Kuijpers, W., & Dijkstra, B. A. G. (2017). Treatment consumption and treatment re-enrollment in GHB-dependent patients in The Netherlands. Drug and Alcohol Dependence, 176, 96–101. https://doi.org/10.1016/j.drugalcdep.2017.02.026
   PubMed Web of Science ®Google Scholar
• Van Sassenbroeck, D. K., De Paepe, P., Belpaire, F. M., Rosseel, M. T., Martens, P., Boon, P. A., & Buylaert, W. A. (2001). Relationship between gamma-hydroxybutyrate plasma concentrations and its electroencephalographic effects in the rat. The Journal of Pharmacy and Pharmacology, 53(12), 1687–1696. https://doi.org/10.1211/0022357011778089
   PubMed Web of Science ®Google Scholar
• Van Sassenbroeck, D. K., De Neve, N., De Paepe, P., Belpaire, F. M., Verstraete, A. G., Calle, P. A., & Buylaert, W. A. (2007). Abrupt awakening phenomenon associated with gamma-hydroxybutyrate use: A case series. Clinical Toxicology, 45(5), 533–538. https://doi.org/10.1080/15563650701365818
   Web of Science ®Google Scholar
• Varela, M. (2004). Gamma hydroxybutirate use for sexual assault. Emergency Medicine Journal, 21(2), 255–256. https://doi.org/10.1136/emj.2002.002402
   PubMed Web of Science ®Google Scholar
• Verdejo-García, A., Bechara, A., Recknor, E. C., & Pérez-García, M. (2006). Executive dysfunction in substance dependent individuals during drug use and abstinence: An examination of the behavioral, cognitive and emotional correlates of addiction. Journal of the International Neuropsychological Society, 12(3), 405–415. https://doi.org/10.1017/S1355617706060486
   PubMed Web of Science ®Google Scholar
• Verdejo-García, A., Bechara, A., Recknor, E. C., & Pérez-García, M. (2007). Negative emotion-driven impulsivity predicts substance dependence problems. Drug and Alcohol Dependence, 91(2–3), 213–219. https://doi.org/10.1016/j.drugalcdep.2007.05.025
   PubMed Web of Science ®Google Scholar
• Wise, R. A. (2008). Dopamine and reward: The anhedonia hypothesis 30 years on. Neurotoxicity Research, 14(2–3), 169–183. https://doi.org/10.1007/BF03033808
   PubMed Web of Science ®Google Scholar
• World Health Organization. (2015). WHO expert committee on drug dependence, 36th report. WHO publications.
   Google Scholar
• World Medical Association.(2013). World medical association declaration of Helsinki ethical principles for medical research involving human subjects (p. 310). WMA General Assembly.
   Google Scholar
• Zvosec, D. L., & Smith, S. W. (2005). Agitation is common in G-hydroxybutyrate toxicity. American Journal of Emergency Medicine, 23(3), 316–320. https://doi.org/10.1016/j.ajem.2005.02.003
   PubMed Web of Science ®Google Scholar
• Zvosec, D. L., Smith, S. W., McCutcheon, J. R., Spillane, J., Hall, B. J., & Peacock, E. A. (2001). Adverse events, including death, associated with the use of 1,4-butanediol. The New England Journal of Medicine, 344(2), 87–94. https://doi.org/10.1056/NEJM200101113440202
   PubMed Web of Science ®Google Scholar